| Title |
Aspirin with or without an antiemetic for acute migraine headaches in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2013
|
| DOI | 10.1002/14651858.cd008041.pub3 |
| Pubmed ID | |
| Authors |
Varo Kirthi, Sheena Derry, R Andrew Moore |
| Abstract |
This is an updated version of the original Cochrane review published in Issue 4, 2010 (Kirthi 2010). Migraine is a common, disabling condition and a burden for the individual, health services and society. Many sufferers choose not to, or are unable to, seek professional help and rely on over-the-counter analgesics. Co-therapy with an antiemetic should help to reduce nausea and vomiting commonly associated with migraine headaches. |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 33% |
| United Kingdom | 4 | 11% |
| Australia | 2 | 6% |
| France | 2 | 6% |
| North Macedonia | 1 | 3% |
| India | 1 | 3% |
| United States | 1 | 3% |
| Netherlands | 1 | 3% |
| Japan | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 11 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 69% |
| Practitioners (doctors, other healthcare professionals) | 8 | 22% |
| Scientists | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Netherlands | 1 | <1% |
| Ecuador | 1 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 169 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 14% |
| Student > Bachelor | 22 | 13% |
| Student > Ph. D. Student | 17 | 10% |
| Student > Doctoral Student | 11 | 6% |
| Researcher | 9 | 5% |
| Other | 26 | 15% |
| Unknown | 65 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 31% |
| Nursing and Health Professions | 12 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Psychology | 8 | 5% |
| Neuroscience | 6 | 3% |
| Other | 17 | 10% |
| Unknown | 68 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2024.
All research outputs
#900,997
of 25,464,544 outputs
Outputs from Cochrane database of systematic reviews
#1,764
of 13,111 outputs
Outputs of similar age
#6,544
of 204,414 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 265 outputs
Altmetric has tracked 25,464,544 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,111 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,414 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 265 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.